Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome

scientific article published on 15 March 2004

Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/B400029C
P698PubMed publication ID15064799

P2093author name stringPing Zhang
David R Bundle
Chang-Chun Ling
Hugh J Willison
Søren M Andersen
Kate Townson
P2860cites workAn Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)Q22250915
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminalQ28186978
Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndromeQ28256385
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndromeQ28297319
The immunopathogenesis of Miller Fisher syndromeQ33850688
Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.Q33853670
Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspectiveQ34955839
Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharideQ36679318
Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndromeQ36760346
Use of diethyl squarate for the coupling of oligosaccharide amines to carrier proteins and characterization of the resulting neoglycoproteins by MALDI-TOF mass spectrometryQ36810831
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.Q37352303
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanomaQ37678574
A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structureQ38314715
Gangliosides and bacterial toxins in Guillain-Barré syndromeQ40840074
Diversity of lipopolysaccharide structures in Campylobacter jejuniQ41660360
Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndromeQ41660366
Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndromeQ41664465
Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndromeQ42275444
Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharidesQ42286088
Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodiesQ42541304
Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndromeQ42551135
Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuniQ42628264
Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosidesQ42669740
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeQ44664722
Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndromeQ45191246
Campylobacter jejuni infection and Guillain-Barré syndrome.Q55063212
A message from the EditorsQ58050038
A D-ribofuranosylamine as glycosyl acceptorQ72018832
Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharidesQ72607999
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter releaseQ72667720
Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosidesQ72884135
A synthetic approach to polysialogangliosides containing alpha-sialyl-(2-->8)-sialic acid: total synthesis of ganglioside GD3Q72920498
Synthesis and conformational studies of the tyvelose capped, Lewis-x like tetrasaccharide epitope of Trichinella spiralisQ73010150
Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndromeQ73766463
Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndromeQ74185180
Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathyQ74595019
Guillain-Barré syndromeQ77326744
Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminalsQ77348546
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end platesQ78170867
P433issue8
P921main subjectoligosaccharideQ320607
P304page(s)1199-1212
P577publication date2004-03-15
P1433published inOrganic and Biomolecular ChemistryQ3355939
P1476titleSynthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome
P478volume2

Reverse relations

cites work (P2860)
Q33372831Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.
Q46558371Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.
Q36994582Gangliosides as targets for autoimmune injury to the nervous system
Q34409385Pathogenesis and treatment of immune-mediated neuropathies
Q36995942Syntheses of Lewis(x) and dimeric Lewis(x): construction of branched oligosaccharides by a combination of preactivation and reactivity based chemoselective one-pot glycosylations
Q36164122The immunobiology of Guillain-Barré syndromes

Search more.